Thomas M. Ross - Oct 10, 2022 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
EVP, Global Sales & Marketing
Signature
/s/ Brian F. Leaf, attorney-in-fact
Stock symbol
MXCT
Transactions as of
Oct 10, 2022
Transactions value $
-$163,693
Form type
4
Date filed
10/12/2022, 04:09 PM
Previous filing
Mar 29, 2022
Next filing
Nov 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Options Exercise $20.9K +24.9K $0.84 24.9K Oct 10, 2022 Direct F1
transaction MXCT Common Stock Sale -$160K -24.9K -100% $6.45 0 Oct 10, 2022 Direct F1, F2
transaction MXCT Common Stock Options Exercise $3.6K +4.28K $0.84 4.28K Oct 11, 2022 Direct F1
transaction MXCT Common Stock Sale -$27.9K -4.28K -100% $6.51 0 Oct 11, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -24.9K -43.6% $0.00 32.1K Oct 10, 2022 Common Stock 24.9K $0.84 Direct F1, F4
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -4.28K -13.32% $0.00 27.9K Oct 11, 2022 Common Stock 4.28K $0.84 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.31 to $6.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.40 to $6.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4 This option is fully vested and exercisable.